![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 27, 25506-25511, July 8, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


**

From the
Departments of
Internal Medicine and||
Radiation Biology, University of Iowa Carver
College of Medicine, Iowa City, Iowa 52242, the**
Veterans Affairs Medical Center, Iowa City, Iowa
52246, and the ¶Baylor Institute of Metabolic
Disease, Dallas, Texas 75226
Expression of the imprinted genes H19 and insulin-like growth
factor 2 (Igf2), which lie in close proximity on mouse chromosome 7,
is regulated by methylation of a differentially methylated domain (DMD)
located 5' to H19. Biallelic expression of H19 has
been observed in renal disease patients with hyperhomocysteinemia, a
cardiovascular disease risk factor. The present study determined whether
hyperhomocysteinemia produces decreased tissue methylation capacity,
hypomethylation of the H19 DMD, and altered expression of
H19 and Igf2 in adult mice. Mice heterozygous for disruption
of the gene for cystathionine-
-synthase (Cbs+/) and
C57BL/6 (Cbs+/+) mice were fed a hyperhomocysteinemic or control
diet, respectively, from weaning until 912 months of age. Higher plasma
total homocysteine (p < 0.001) was found in hyperhomocysteinemic
mice than in control mice (95 ± 12 versus 5.0 ± 0.3
µmol/liter). Hyperhomocysteinemia was accompanied by higher levels of
S-adenosylhomocysteine (p < 0.05) and lower
S-adenosylmethionine/S-adenosylhomocysteine ratios
(p < 0.001) in liver and brain. The effect of hyperhomocysteinemia
on H19 DMD methylation was tissue-specific. In liver,
hyperhomocysteinemic mice had decreased H19 DMD methylation
(p < 0.001). In brain, hyperhomocysteinemia was accompanied by
increased H19 DMD methylation (p < 0.001) and a decrease
in the ratio of H19/Igf2 transcripts (p < 0.05).
In aorta, hyperhomocysteinemia produced an increase in H19 DMD
methylation (p < 0.001) and a 2.5-fold increase in expression of
H19 transcripts (p < 0.05). Levels of H19
transcripts in aorta correlated positively with plasma total homocysteine
concentration (p < 0.05, r = 0.620). We conclude that
hyperhomocysteinemia produces tissue-specific changes in H19 DMD
methylation and increased vascular expression of H19 in adult
mice.
Received for publication, May 2, 2005 , and in revised form, May 17, 2005.
* This work was supported by the Office of Research and Development, United States Department of Veterans Affairs, National Institutes of Health Grants HL63943 and NS24621, and American Heart Association Beginning Grant-in-aid 0465315Z (to A. M. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Nutrition Research Program, University of British
Columbia, BC Research Institute for Children's and Women's Health, 950 West
28th Ave., Vancouver, Canada.

To whom correspondence should be addressed: Dept. of Internal Medicine, C32
GH, The University of Iowa, IA 52242. Tel.: 319-356-4048; Fax: 319-335-8848;
E-mail:
steven-lentz{at}uiowa.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Dayal and S. R. Lentz Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes Arterioscler. Thromb. Vasc. Biol., September 1, 2008; 28(9): 1596 - 1605. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dayal, R. N. Rodionov, E. Arning, T. Bottiglieri, M. Kimoto, D. J. Murry, J. P. Cooke, F. M. Faraci, and S. R. Lentz Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H816 - H825. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Y. Chang, S.-C. Lu, C.-M. Lee, Y.-J. Chen, T. A. Dugan, W.-H. Huang, S.-F. Chang, W. S.L. Liao, C.-H. Chen, and Y.-T. Lee Homocysteine Inhibits Arterial Endothelial Cell Growth Through Transcriptional Downregulation of Fibroblast Growth Factor-2 Involving G Protein and DNA Methylation Circ. Res., April 25, 2008; 102(8): 933 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
A D. Smith, Y.-I. Kim, and H. Refsum Is folic acid good for everyone? Am. J. Clinical Nutrition, March 1, 2008; 87(3): 517 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Devlin, R. Singh, R. E. Wade, S. M. Innis, T. Bottiglieri, and S. R. Lentz Hypermethylation of Fads2 and Altered Hepatic Fatty Acid and Phospholipid Metabolism in Mice with Hyperhomocysteinemia J. Biol. Chem., December 21, 2007; 282(51): 37082 - 37090. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sontag, V. Nunbhakdi-Craig, J.-M. Sontag, R. Diaz-Arrastia, E. Ogris, S. Dayal, S. R. Lentz, E. Arning, and T. Bottiglieri Protein Phosphatase 2A Methyltransferase Links Homocysteine Metabolism with Tau and Amyloid Precursor Protein Regulation J. Neurosci., March 14, 2007; 27(11): 2751 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dayal, K. M. Wilson, L. Leo, E. Arning, T. Bottiglieri, and S. R. Lentz Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia Blood, October 1, 2006; 108(7): 2237 - 2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Devlin and S. R. Lentz ApoA-I: A Missing Link Between Homocysteine and Lipid Metabolism? Circ. Res., March 3, 2006; 98(4): 431 - 433. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |